There is much evidence showing the role of CDK5 in the migration of numerous cancers, including pancreatic cancer [150], breast cancer [9], lung cancer [151], liver cancer [139], glioblastoma [152], prostate cancer [102], and pituitary cancer [153]. This evidence concerns the gene CDK5 and prostate carcinoma.